Segall Bryant & Hamill, LLC Galapagos Nv Transaction History
Segall Bryant & Hamill, LLC
- $7.07 Billion
- Q4 2024
A detailed history of Segall Bryant & Hamill, LLC transactions in Galapagos Nv stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 685,867 shares of GLPG stock, worth $17.7 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
685,867
Previous 705,648
2.8%
Holding current value
$17.7 Million
Previous $20.3 Million
7.16%
% of portfolio
0.27%
Previous 0.28%
Shares
8 transactions
Others Institutions Holding GLPG
# of Institutions
91Shares Held
13.2MCall Options Held
213KPut Options Held
126K-
Tang Capital Management LLC San Diego, CA2.16MShares$55.8 Million4.46% of portfolio
-
Bvf Inc San Francisco, CA1.57MShares$40.5 Million1.62% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$36.4 Million0.96% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$26.5 Million8.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT781KShares$20.2 Million0.95% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.7B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...